Application Nr Approved Date Route Status External Links
ANDA202912 None Oral None Google , Wikipedia , PubMed , DailyMed , Raw OpenFDA , ECHA , ToxNet , JECFA , FAO , 21 CFR

Indications and Purposes

1 Indications And Usage Abacavir, Lamivudine And Zidovudine Tablet, A Combination Of Abacavir, Lamivudine, And Zidovudine, Each Nucleoside Analogue Hiv-1 Reverse Transcriptase Inhibitors, Is Indicated In Combination With Other Antiretroviral Agents For The Treatment Of Hiv-1 Infection.( 1 ) Abacavir, Lamivudine And Zidovudine Tablet Is Indicated In Combination With Other Antiretrovirals Or Alone For The Treatment Of Human Immunodeficiency Virus Type 1 (hiv-1) Infection. Limitations Of Use: Limited Data Exist On The Use Of Abacavir, Lamivudine And Zidovudine Tablets Alone In Patients With Higher Baseline Viral Load Levels (greater Than 100,000 Copies Per Ml) [see Clinical Studies ( 14 )] .

All Formulated Excipients (0 Total)

None

Active Ingredients ( 3 Total)

Name Structure ZINC ID(s)
1. Abacavir Sulfate ABACAVIR SULFATE ZINC2015928
2. Lamivudine LAMIVUDINE ZINC12346
3. Zidovudine ZIDOVUDINE ZINC3779042

Comments